Amneal Pharmaceuticals, LLC Credit Rating

Usuarios Registrados

Registro para acceso total permitido. Su código de acceso es sensible a mayúsculas y minúsculas.

Nombre de Usuario:

Código de Acceso:

Ingresarme automáticamente en mi próxima visita

Entrar

¿Olvidó su Nombre de Usuario o Código de Acceso?

¿No se ha registrado?

Regístrese ahora para tener acceso GRATUITO a:

Calificaciones de Emisor.

Calificaciones de más de 170,000 instrumentos corporativos, gubernamentales y de finanzas estructuradas.

Calendario de Eventos.

Información de cursos, seminarios y teleconferencias.

Listas de Calificaciones en Observación.

Listados de emisores en revisión para posible cambio de calificación.

Metodologías de Calificación.

Marco de Metodología respaldando todas las calificaciones de Moody’s.

Resultados 1 - 42 de 42

Página 1 de 1 Next

Filtrar por:

Fecha	Tipo de Reporte	Título	Fuente
26 Oct 2023	Credit Opinion	Amneal Pharmaceuticals, LLC: Update to credit analysis following affirmation of B2 CFR	Moody's Investors Service
24 Oct 2023	Rating Action	Moody's assigns B2 rating to Amneal's proposed first lien term loan, affirms ratings	Moody's Investors Service
27 Jul 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
20 Oct 2022	Credit Opinion	Amneal Pharmaceuticals, LLC: Update to credit analysis	Moody's Investors Service
04 Oct 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
08 Nov 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Amneal Pharmaceuticals, LLC	Moody's Investors Service
14 Oct 2021	Credit Opinion	Amneal Pharmaceuticals, LLC: Update following upgrade to B2 CFR	Moody's Investors Service
13 Oct 2021	Rating Action	Moody's upgrades Amneal's CFR to B2; outlook stable	Moody's Investors Service
24 Feb 2021	Credit Opinion	Amneal Pharmaceuticals, LLC: Update to credit analysis	Moody's Investors Service
15 Dec 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Amneal Pharmaceuticals, LLC	Moody's Investors Service
28 Feb 2020	Credit Opinion	Amneal Pharmaceuticals, LLC: Update following downgrade to B3 CFR; stable outlook	Moody's Investors Service
26 Feb 2020	Rating Action	Moody's downgrades Amneal's CFR to B3; outlook changed to stable	Moody's Investors Service
14 Jan 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Amneal Pharmaceuticals, LLC	Moody's Investors Service
07 Nov 2019	Rating Action	Moody's places Amneal's B2 ratings under review for downgrade	Moody's Investors Service
17 Jul 2019	Credit Opinion	Amneal Pharmaceuticals, LLC: Update following downgrade to B2 CFR	Moody's Investors Service
11 Jul 2019	Rating Action	Moody's downgrades Amneal's CFR to B2; outlook stable	Moody's Investors Service
19 Mar 2019	Credit Opinion	Amneal Pharmaceuticals, LLC: Update following outlook change to stable	Moody's Investors Service
15 Mar 2019	Rating Action	Moody's affirms Amneal's B1 ratings; outlook revised to stable	Moody's Investors Service
15 Feb 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Amneal Pharmaceuticals, LLC	Moody's Investors Service
13 Jul 2018	LGD Assessment	Amneal Pharmaceuticals Holding Company, LLC	Moody's Investors Service
08 Mar 2018	Credit Opinion	Amneal Pharmaceuticals, LLC: Update following outlook change to positive	Moody's Investors Service
06 Mar 2018	Rating Action	Moody's rates Amneal's new term loan B1; outlook revised to positive	Moody's Investors Service
30 Nov 2017	Credit Opinion	Amneal Pharmaceuticals, LLC: Update to credit analysis	Moody's Investors Service
23 Oct 2017	Issuer Comment	Impax Laboratories, Inc.: Impax and Amneal’s All-Stock Merger Is Credit Positive	Moody's Investors Service
17 Oct 2017	Rating Action	Moody's affirms Amneal's B1 CFR; outlook stable	Moody's Investors Service
22 Mar 2017	Announcement	Moody's: Amneal's dividend recap is credit negative but does not change the ratings	Moody's Investors Service
22 Mar 2017	Issuer Comment	Amneal Pharmaceuticals, LLC: Amneal's dividend recap is credit negative but does not change the ratings	Moody's Investors Service
30 Nov 2016	Credit Opinion	Amneal Pharmaceuticals, LLC: Update to Discussion of Key Credit Factors	Moody's Investors Service
12 May 2016	Rating Action	Moody's Affirms Amneal's Ratings; Outlook Stable	Moody's Investors Service
31 Mar 2016	Issuer Comment	Generic Voltaren Gel Launch Is Credit Positive for Amneal and Negative for Endo	Moody's Investors Service
25 Mar 2016	Issuer Comment	Amneal Pharmaceuticals and Endo Luxembourg Finance Company: Generic Voltaren Gel launch is positive for Amneal and negative for Endo	Moody's Investors Service
01 Dec 2015	Credit Opinion	Amneal Pharmaceuticals, LLC	Moody's Investors Service
08 Apr 2015	Issuer Comment	Amneal Pharmaceuticals, LLC: Amneal dividend credit negative; no change to ratings or outlook	Moody's Investors Service
08 Dec 2014	Announcement	Correction to Text, 4 December 2014 Release: Moody's Upgrades Amneal to B1; Stable Outlook	Moody's Investors Service
04 Dec 2014	Rating Action	Moody's Upgrades Amneal to B1; Stable Outlook	Moody's Investors Service
02 Jul 2014	Announcement	Moody's: FDA's approval of Roxane's buprenorphine is credit negative for Amneal	Moody's Investors Service
02 Jul 2014	Issuer Comment	Moody's: FDA's approval of Roxane's buprenorphine is credit negative for Amneal	Moody's Investors Service
24 Jun 2014	Rating Action	Moody's changes Amneal's outlook to positive	Moody's Investors Service
01 Nov 2013	Special Comment	FDA Move to Restrict Certain Pain Relievers is Credit Negative for Generic Drug Makers	Moody's Investors Service
21 Oct 2013	Announcement	Moody's: Amneal's deal modifications credit positive -- ratings unaffected	Moody's Investors Service
21 Oct 2013	Issuer Comment	Moody's: Amneal's deal modifications credit positive - ratings unaffected	Moody's Investors Service
04 Oct 2013	Rating Action	Moody's rates Amneal B2; outlook stable	Moody's Investors Service

Resultados 1 - 42 de 42

Página 1 de 1 Next

Estudios & Calificaciones

Productos & Soluciones

Noticias & Eventos

Usuarios Registrados

¿No se ha registrado?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: